000 | 01691 a2200457 4500 | ||
---|---|---|---|
005 | 20250513080815.0 | ||
264 | 0 | _c19930413 | |
008 | 199304s 0 0 eng d | ||
022 | _a0894-9255 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKrentz, A J | |
245 | 0 | 0 |
_aAnthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. _h[electronic resource] |
260 |
_bJournal of acquired immune deficiency syndromes _cMar 1993 |
||
300 |
_a245-51 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAIDS-Related Complex _xblood |
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBody Composition _xdrug effects |
650 | 0 | 4 |
_aBody Water _xdrug effects |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aGrowth Hormone _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscles _xdrug effects |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_abeta 2-Microglobulin _xmetabolism |
700 | 1 | _aKoster, F T | |
700 | 1 | _aCrist, D M | |
700 | 1 | _aFinn, K | |
700 | 1 | _aJohnson, L Z | |
700 | 1 | _aBoyle, P J | |
700 | 1 | _aSchade, D S | |
773 | 0 |
_tJournal of acquired immune deficiency syndromes _gvol. 6 _gno. 3 _gp. 245-51 |
|
999 |
_c8449673 _d8449673 |